These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 June. The technology gains life-saving medical insights by analysing human excrement. Societas interposita seriei trium patentium elementorum involucrum suum sensorem CULTUS medici.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Europa, Iaponia et China.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Technologia sine sensu cognoscere potest fontem sanguinis in tractu gastro.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Secundum Sensum CEO Yfat Scialom, who predicts that “cum explosione digital medicina, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, morbus alvus inflammatione et infectiones tractus urinarii.

Its solution consists of a multispectral optical sensor, lumen fons et sui iuris protegendo fabrica quod includit WiFi nexu. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Informatio de gustatum sanguine, coniuncta cum additional analysis temporis de sanguine ad excretionem, singula praebet pathologia sanguinem. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense nuntiatum est CommuniCare, magna curis comitatu plus quam 90 healthcare facilities in the US, hoc anno technology gubernatori incipiam. Praeter haec gubernator, OutSense also plans to conduct clinical trials in Israel and Japan.

Visit More News at Viga.cc News